Health
Pfizer says BNT162b2 vaccine is effective against new Covid strains – Pharmaceutical Business Review
Pfizer said that BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus.
Pfizer and BioNTech said that their Covid-19 vaccine BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus as per the results from an in vitro study.
The in vitro study, which was held by Pfizer and the University of Texas Medical Branch (UTMB), demonstrated that the antibodies from people subjected to the vaccine could effectively work against the rapidly spreading variants.
Reported initially in the UK and South Africa,…
-
Noosa News23 hours agoMajor flood arrives at Birdsville
-
Business8 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
General14 hours agoVolodymyr Zelenskyy claims Chinese soldiers fighting alongside Russians in Ukraine
-
General20 hours agoHow what happens on financial markets affects the broader economy